alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 87, Number 118 (Tuesday, June 21, 2022)]
[Notices]
[Page 36866]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13238]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Institute 
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Career Development (Ks) and 
Conference Support (R13) Review.
    Date: July 19, 2022.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Democracy II, 6707 
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 
20892, (301) 496-4773, <a href="/cdn-cgi/l/email-protection#02786a6d7770426f636b6e2c6c6b6a2c656d74"><span class="__cf_email__" data-cfemail="c9b3a1a6bcbb89a4a8a0a5e7a7a0a1e7aea6bf">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health, HHS)

    Dated: June 15, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13238 Filed 6-17-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# Official Journal L 335/2016

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 335 |
| | |
| English edition | Legislation | Volume 599 December 2016 |

ISSN 1977-0677

Official Journal

of the European Union

L 335

English edition

Legislation

Volume 599 December 2016

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | ACTS ADOPTED BY BODIES CREATED BY INTERNATIONAL AGREEMENTS |
| | * | Decision No 1/2016 of the Geographical Indications Sub-Committee of 18 October 2016 amending Annexes XXX-C and XXX-D to the Association Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and the Republic of Moldova, of the other part [2016/2127] | 1 |
| | * | Decision No 1/2016 of the Geographical Indications Sub-Committee of 10 November 2016 amending Annex XVII-C and Part B of Annex XVII-D to the Association Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and Georgia, of the other part [2016/2128] | 133 |

Contents

II   Non-legislative acts

page

ACTS ADOPTED BY BODIES CREATED BY INTERNATIONAL AGREEMENTS

*

Decision No 1/2016 of the Geographical Indications Sub-Committee of 18 October 2016 amending Annexes XXX-C and XXX-D to the Association Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and the Republic of Moldova, of the other part [2016/2127]

1

*

Decision No 1/2016 of the Geographical Indications Sub-Committee of 10 November 2016 amending Annex XVII-C and Part B of Annex XVII-D to the Association Agreement between the European Union and the European Atomic Energy Community and their Member States, of the one part, and Georgia, of the other part [2016/2128]

133

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Jesus Oscar Meraz LEON, Petitioner v. Charles L. RYAN, Director, Arizona Department of Corrections, et al.

No. 19-5912

Supreme Court of the United States.

October 21, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

1139 

CA 11-01347 

PRESENT: SCUDDER, P.J., SMITH, FAHEY, CARNI, AND VALENTINO, JJ. 

 

 

LYNN M. DELBELLO, PLAINTIFF-RESPONDENT, 

V MEMORANDUM AND ORDER

THOMAS M. DELBELLO, DEFENDANT-APPELLANT. 

(APPEAL NO. 2.) 

 

THOMAS M. DELBELLO, DEFENDANT-APPELLANT PRO SE. 

KENNEY SHELTON LIPTAK NOWAK LLP, BUFFALO (LAURA J. EMERSON OF

COUNSEL), FOR PLAINTIFF-RESPONDENT. 

 

Appeal from a judgment of the Supreme Court, Erie County (John F.

O’Donnell, J.), entered December 2, 2010 in a divorce action. The

judgment, inter alia, directed defendant to pay maintenance to

plaintiff in the amount of $200 per week.

It is hereby ORDERED that the judgment so appealed from is

unanimously modified on the law by vacating the amount of maintenance

awarded and as modified the judgment is affirmed without costs and the

matter is remitted to Supreme Court, Erie County, for further

proceedings in accordance with the same Memorandum as in Delbello v

Delbello ([appeal No. 1] ___ AD3d ___ [Nov. 9, 2012]).

Entered: November 9, 2012 Frances E. Cafarell

Clerk of the Court
# C_2018110EN.01000101.xml

| 23.3.2018 | EN | Official Journal of the European Union | C 110/1 |
| --- | --- | --- | --- |

23.3.2018

EN

Official Journal of the European Union

C 110/1

---

Non-opposition to a notified concentration

(Case M.8784 — Frankfurter Leben Holding/Pro bAV Pensionskasse)

(Text with EEA relevance)

(2018/C 110/01)

On 19 March 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8784. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8784. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1240 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 1240

   To extend the low-interest refinancing provisions under the Local 
Development Business Loan Program of the Small Business Administration.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 18, 2013

  Ms. Chu (for herself, Ms. Meng, Mr. Payne, Mrs. Negrete McLeod, Ms. 
    Bordallo, Mr. Schrader, Ms. Tsongas, Mr. Petri, and Mr. Bera of 
 California) introduced the following bill; which was referred to the 
                      Committee on Small Business

_______________________________________________________________________

                                 A BILL

 
   To extend the low-interest refinancing provisions under the Local 
Development Business Loan Program of the Small Business Administration.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Commercial Real Estate and Economic 
Development Act of 2013'' or the ``CREED Act of 2013''.

SEC. 2. LOW-INTEREST REFINANCING UNDER THE LOCAL DEVELOPMENT BUSINESS 
              LOAN PROGRAM.

    (a) Repeal.--Section 1122(b) of the Small Business Jobs Act of 2010 
(15 U.S.C. 696 note) is repealed.
    (b) Restoration of Low-Interest Refinancing Provision.--
Subparagraph (C) of section 502(7) of the Small Business Investment Act 
of 1958 (15 U.S.C. 696(7)) (relating to refinancing not involving 
expansions), as in effect on September 25, 2012, shall be in effect 
during the period beginning on the date of enactment of this Act and 
ending 5 years after such date of enactment.

SEC. 3. NO ADDITIONAL APPROPRIATIONS AUTHORIZED.

    The amendments made by section 2 do not authorize any 
appropriations for the purpose of carrying out such amendment or the 
program it amends.
                                 <all>
```
I 

113TH CONGRESS 

1ST SESSION H. R. 1311 

To prohibit certain grants under the Child Abuse Prevention and Treatment 

Act to States that do not provide for certain minimal terms of imprisonment for certain child abusers, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 21, 2013 

Mr. PITTENGER introduced the following bill; which was referred to the Committee on Education and the Workforce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by 

the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To prohibit certain grants under the Child Abuse Prevention 

and Treatment Act to States that do not provide for 

certain minimal terms of imprisonment for certain child 

abusers, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Kilah Davenport Child 

5 Protection Act of 2013’’. 


pwalker on DSK7TPTVN1PROD with BILLS
2 

•HR 1311 IH

1 SEC. 2. IN GENERAL. 

2 The Secretary of Health and Human Services may 

3 not make a grant under section 106 or under title II of 

4 the Child Abuse Prevention and Treatment Act (42 U.S.C. 

5 5101 et seq.) to a State until the date on which that 

6 State’s laws provide for a criminal punishment including 

7 a term of imprisonment of not less than 3,800 days for 

8 any individual who— 

9 (1) is a parent or any other individual providing 

10 care to or supervision of a child of less than 16 

11 years of age; and 

12 (2) intentionally— 

13 (A) inflicts any serious bodily injury (as 

14 such term is defined in section 1365(h)(3) of 

15 title 18, United States Code) on that child; or 

16 (B) commits an assault upon that child 

17 which results in— 

18 (i) any serious bodily injury (as such 

19 term is defined in section 1365(h)(3) of 

20 title 18, United States Code) to the child; 

21 or 

22 (ii) permanent or protracted loss or 

23 impairment of any mental or emotional 

24 function of the child. 


pwalker on DSK7TPTVN1PROD with BILLS
3 

•HR 1311 IH

1 SEC. 3. EXPANSION OF PREDICATE FOR INCREASED PEN2 ALTIES FOR CERTAIN DOMESTIC ASSAULTS. 

3 Section 117(a)(1) of title 18, United States Code, is 

4 amended by inserting ‘‘, or against the child of or in the 

5 care of the person committing the domestic assault’’ after 

6 ‘‘intimate partner’’. 

7 SEC. 4. EFFECTIVE DATE. 

8 (a) IN GENERAL.—The provisions of this Act, except 

9 as otherwise provided in subsection (b), shall take effect 

10 beginning on the date of enactment of this Act. 

11 (b) EXCEPTION.—Section 2 of this Act shall take ef12 fect beginning on the date that is 2 years after the date 

13 of enactment of this Act. 

Æ 


pwalker on DSK7TPTVN1PROD with BILLS
Zsolt PETKO, et al., Petitioners v. CARELTON COURTYARD

No. 18-1573

Supreme Court of the United States.

December 16, 2019

Petition for rehearing denied.
[ARTICLE] 6
[CIK] 0000880583
[NAME] MFS RESEARCH PORTFOLIO
[SERIES]
   [NUMBER] 19
   [NAME] THE TRAVELERS SERIES TRUST
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   YEAR
[FISCAL-YEAR-END]                          DEC-31-1999
[PERIOD-END]                               DEC-31-1999
[INVESTMENTS-AT-COST]                      127,254,453
[INVESTMENTS-AT-VALUE]                     152,368,661
[RECEIVABLES]                                  487,006
[ASSETS-OTHER]                                  65,433
[OTHER-ITEMS-ASSETS]                                 0
[TOTAL-ASSETS]                             152,921,100
[PAYABLE-FOR-SECURITIES]                       734,208
[SENIOR-LONG-TERM-DEBT]                              0
[OTHER-ITEMS-LIABILITIES]                      113,842
[TOTAL-LIABILITIES]                            848,050
[SENIOR-EQUITY]                                      0
[PAID-IN-CAPITAL-COMMON]                   123,890,596
[SHARES-COMMON-STOCK]                       11,648,150
[SHARES-COMMON-PRIOR]                        3,587,001
[ACCUMULATED-NII-CURRENT]                            0
[OVERDISTRIBUTION-NII]                               0
[ACCUMULATED-NET-GAINS]                      2,949,147
[OVERDISTRIBUTION-GAINS]                             0
[ACCUM-APPREC-OR-DEPREC]                    25,233,307
[NET-ASSETS]                               152,073,050
[DIVIDEND-INCOME]                              626,367
[INTEREST-INCOME]                               21,165
[OTHER-INCOME]                                       0
[EXPENSES-NET]                                 846,527
[NET-INVESTMENT-INCOME]                         21,165
[REALIZED-GAINS-CURRENT]                     3,598,231
[APPREC-INCREASE-CURRENT]                   21,064,476
[NET-CHANGE-FROM-OPS]                       24,683,872
[EQUALIZATION]                                       0
[DISTRIBUTIONS-OF-INCOME]                            0
[DISTRIBUTIONS-OF-GAINS]                             0
[DISTRIBUTIONS-OTHER]                                0
[NUMBER-OF-SHARES-SOLD]                      8,114,832
[NUMBER-OF-SHARES-REDEEMED]                     53,683
[SHARES-REINVESTED]                                  0
[NET-CHANGE-IN-ASSETS]                     114,202,609
[ACCUMULATED-NII-PRIOR]                       (10,432)
[ACCUMULATED-GAINS-PRIOR]                    (659,817)
[OVERDISTRIB-NII-PRIOR]                              0
[OVERDIST-NET-GAINS-PRIOR]                           0
[GROSS-ADVISORY-FEES]                          735,474
[INTEREST-EXPENSE]                                   0
[GROSS-EXPENSE]                                846,527
[AVERAGE-NET-ASSETS]                        85,833,355
[PER-SHARE-NAV-BEGIN]                            10.56
[PER-SHARE-NII]                                   0.00
[PER-SHARE-GAIN-APPREC]                           2.50
[PER-SHARE-DIVIDEND]                              0.00
[PER-SHARE-DISTRIBUTIONS]                         0.00
[RETURNS-OF-CAPITAL]                                 0
[PER-SHARE-NAV-END]                              13.06
[EXPENSE-RATIO]                                   0.99
</TABLE>
SMITH BARNEY INVESTMENT TRUST
On behalf of the
Smith Barney S&P 500 Index Fund
Smith Barney U.S. 5000 Index Fund
Smith Barney EAFE Index Fund

Supplement dated August 23, 2000
to the Prospectus dated April 28, 2000

The following information supplements, and to the
extent inconsistent therewith, supersedes, the
information in the Prospectus:

Smith Barney EAFE Index Fund

Effective September 5, 2000, the name of the Smith
Barney EAFE Index Fund will change to Smith Barney
International Index Fund.

All Funds

Effective September 5, 2000 Class D shares of each
fund will be redesignated as follows:

	Smith Barney S&P 500 Index Fund
Class D shares renamed Citi S&P 500 Index
Shares

 Smith Barney U.S. 5000 Index Fund
	Class D shares renamed Citi U.S. 5000
Index Shares

Smith Barney International Index Fund
	Class D shares renamed Citi International
Index Shares


Smith Barney U.S. 5000 Index Fund and Smith Barney
International Index Fund

Effective September 5, 2000, Smith Barney U.S. 5000
Index Fund and the Smith Barney International Index
Fund will each charge a redemption fee, payable to
the Fund, on the sale or exchange of any shares
purchased on or after September 5, 2000 and held for
less than 180 days. Shares purchased prior to
September 5, 2000 are not subject to redemption fees.
The redemption fees are as follows:

	Smith Barney U.S. 5000 Index Fund
		Citi U.S. 5000 Index Shares
	0.75% within 180 days

Smith Barney International Index Fund
		Citi International Index Shares
	1.50% within 180 days

The purpose of the redemption fee is to offset
certain expenses incurred to meet redemptions and to
discourage short-term trading in a vehicle intended
for long-term investment.

The Smith Barney S&P 500 Index Fund has no redemption
fees.

Exchanging shares

You may exchange shares only for shares of the same
class.  Effective September 11, 2000, additional
funds will be available for exchange. Contact your
Salomon Smith Barney Financial Consultant for more
information.

		FD 01992
# C_2018338EN.01000702.xml

| 21.9.2018 | EN | Official Journal of the European Union | C 338/7 |
| --- | --- | --- | --- |

21.9.2018

EN

Official Journal of the European Union

C 338/7

---

Non-opposition to a notified concentration

(Case M.9024 — Abry Partners/Link)

(Text with EEA relevance)

(2018/C 338/03)

On 17 September 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9024. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M9024. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# CE2004084EN.01023701.xml

| 3.4.2004 | EN | Official Journal of the European Union | CE 84/237 |
| --- | --- | --- | --- |

3.4.2004

EN

Official Journal of the European Union

CE 84/237

---

(2004/C 84 E/0280)

WRITTEN QUESTION P-3414/03

by Marianne Eriksson (GUE/NGL) to the Council

(12 November 2003)

Subject:   Estonia and directives on equal opportunities

Subject:

It has come to my notice that Estonia has yet to transpose the EU directives on equal opportunities into national legislation. This would seem remarkable, particularly since the Commission publicly criticised the enlargement countries on 6 November for not meeting requirements ahead of EU accession. On that occasion, however, there was no mention of Estonia and the absence of legislation on equal opportunities.

Can the Council confirm that Estonia has not implemented the directives on equal opportunities?

Can the Council explain why it was not made a requirement for accession to the EU?

What action will the Council take?

Reply

(9 March 2004)

(9 March 2004)

Although Estonia has reached a high level of alignment with the acquis in most policy areas, the Council can confirm that Estonia has not yet transposed legislation in the field of equal treatment of women and men. In this context, it should be noted that the Commission's comprehensive monitoring report of 5 November 2003 on Estonia's preparations for membership clearly identifies this issue as a matter of serious concern, where Estonia must take immediate and decisive action if it is to be ready by the date of accession. The Council shares the analysis of the Commission in this regard. It should also be noted that alignment with the acquis in the field of equal opportunities is indeed a requirement for accession (as is the EU acquis as a whole), and that Estonia will achieve this through the adoption of the Gender Equality and Equal Treatment Act and the Employment Contract Act. Estonia is now required to address urgently the substantial delays in the adoption of these two legal acts compared to the original legislative timetable.

In general terms, it should be recalled that the Council has underlined the importance of the process of monitoring the state of preparedness for EU membership of the ten acceding States. This process is an ongoing exercise, which will continue until the date of accession. In this regard, the Council, at its meeting on 17 November 2003, noted that the Commission, taking full advantage of the expertise of the Member States, will continue to follow the acceding States' progress closely using all the means at its disposal to ensure the proper implementation of the Union's rules and policies. Taking into account the Commission's role to safeguard the smooth functioning of all EU policies upon and after accession, the Council also noted the Commission's determination to take, wherever necessary, all appropriate measures for this purpose. Furthermore, the Council took note of the Commission's intention to keep the Council fully and regularly informed on any remaining concerns and on the appropriate measures that it will take in this regard.

---